Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Menveo (MenACWY-CRM vaccine)
print preview
bookmark
share with colleague
General Information
Company
Novartis AG
Description
Quadrivalent meningitis vaccine containing antigens for type A, C, W-135 and Y bacteria
Molecular Target
Mechanism of Action
Vaccine
Latest Stage of Development
Marketed
Indication
Meningitis
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information